Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Neuphoria Therapeutics (NEUP) Non-Current Receivables (2021)

Neuphoria Therapeutics has reported Non-Current Receivables over the past 1 years, most recently at $17841.0 for Q4 2021.

  • Quarterly Non-Current Receivables changed N/A to $17841.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $17841.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $154174.3 for FY2021, N/A changed from the prior year.
  • Non-Current Receivables was $17841.0 for Q4 2021 at Neuphoria Therapeutics, down from $154174.3 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $154174.3 in Q2 2021 and troughed at $17841.0 in Q4 2021.